Friday, April 19, 2013

There has always been controversy around Intuitive Surgical (Nasdaq:ISRG) and its daVinci robotic surgical system. In recent months this controversy has reignited over allegations that device malfunctions/adverse events are increasing and that the system is little more than an expensive, unnecessary toy in procedures like minimally invasive hysterectomy. Making matters worse, this has long been an expensive stock where success has been predicated on double-digit growth in minimally invasive surgery and Intuitive's share in the market.

Please click below for more:
http://www.investopedia.com/stock-analysis/041913/controversy-about-robotassisted-surgery-showing-intuitive-surgicals-numbers-isrg-cov-jnj-syk-mako.aspx

0 comments:

Post a Comment